These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35637021)

  • 1. Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity.
    Fieber JH; Fayanju OM
    Am J Surg; 2022 Oct; 224(4):1038. PubMed ID: 35637021
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic.
    Zhou JZ; Kane S; Ramsey C; Akhondzadeh M; Banerjee A; Shatsky R; Gold KA
    JAMA Netw Open; 2022 Feb; 5(2):e2148581. PubMed ID: 35166787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.
    Toss A; Lambertini M; Punie K; Grandi G; Cortesi L
    Int J Cancer; 2020 Dec; 147(12):3574-3575. PubMed ID: 32557656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Collateral damages of the Covid-19 pandemic in breast cancer screening].
    Villaseñor-Navarro Y; Sollozo-Dupont I
    Salud Publica Mex; 2021 Jun; 63(4):461. PubMed ID: 35077083
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan.
    Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM
    Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
    Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
    Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.
    Labaki C; Bakouny Z; Schmidt A; Lipsitz SR; Rebbeck TR; Trinh QD; Choueiri TK
    Cancer Cell; 2021 Aug; 39(8):1042-1044. PubMed ID: 34265251
    [No Abstract]   [Full Text] [Related]  

  • 8. Hindsight is 2020: Understanding the Impact of the COVID-19 Pandemic on a Provincial Population-Based Breast Screening Program.
    Bentley H; Woods R; Mar C; Tang T; Raveinthiranathan N; Kellow Z; Yong-Hing CJ
    Can Assoc Radiol J; 2022 Aug; 73(3):589-591. PubMed ID: 34758655
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review.
    Tsapatsaris A; Babagbemi K; Reichman MB
    Clin Imaging; 2022 Feb; 82():224-227. PubMed ID: 34896935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation.
    Budukh AM; Dikshit R; Chaturvedi P
    Int J Cancer; 2021 Oct; 149(8):1619-1620. PubMed ID: 34152021
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of the Covid-19 pandemic on breast cancer early detection and screening.
    ; Figueroa JD; Gray E; Pashayan N; Deandrea S; Karch A; Vale DB; Elder K; Procopio P; van Ravesteyn NT; Mutabi M; Canfell K; Nickson C
    Prev Med; 2021 Oct; 151():106585. PubMed ID: 34217412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia.
    Feletto E; Grogan P; Nickson C; Smith M; Canfell K
    Public Health Res Pract; 2020 Dec; 30(4):. PubMed ID: 33294902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan.
    Toyoda Y; Katanoda K; Ishii K; Yamamoto H; Tabuchi T
    Breast Cancer; 2021 Nov; 28(6):1340-1345. PubMed ID: 34241799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.
    Marcondes FO; Cheng D; Warner ET; Kamran SC; Haas JS
    Prev Med; 2021 Oct; 151():106640. PubMed ID: 34217419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.
    Schifferdecker KE; Vaclavik D; Wernli KJ; Buist DSM; Kerlikowske K; Sprague BL; Henderson LM; Johnson D; Budesky J; Jackson-Nefertiti G; Miglioretti DL; Tosteson ANA
    Prev Med; 2021 Oct; 151():106542. PubMed ID: 34217409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cancer screening restart strategies after COVID-19 disruption.
    Kregting LM; Kaljouw S; de Jonge L; Jansen EEL; Peterse EFP; Heijnsdijk EAM; van Ravesteyn NT; Lansdorp-Vogelaar I; de Kok IMCM
    Br J Cancer; 2021 Apr; 124(9):1516-1523. PubMed ID: 33723386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 BreastScreen Department - beyond the pandemic.
    Spuur KM
    J Med Radiat Sci; 2020 Dec; 67(4):352-355. PubMed ID: 33026711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA testing delay during the COVID-19 pandemic: How to act?
    Minucci A; Scambia G; De Bonis M; De Paolis E; Santonocito C; Fagotti A; Capoluongo E; Concolino P; Urbani A
    Mol Biol Rep; 2021 Jan; 48(1):983-987. PubMed ID: 33313973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.